Msn Laboratories Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is RIFAXIMIN [ROUTE CODE "RFa"], with a corresponding US DMF Number 28097.
Remarkably, this DMF maintains an Active status since its submission on March 28, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 27, 2015, and payment made on September 18, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II